Meet the Editor-in-Chief for Discover Oncology

Professor Eleonora Candi, Editor-in-Chief

EIC-Oncology-Candi-website-eic-page-228x221“Discover Oncology, being a broad-scope cancer research and oncology journal, will meet the needs of the scientific community in this growing field. The broad spectrum of cancer-related topics will give researchers and clinicians the opportunity to share their advances in the field and get a whole picture of novelties, hot topics and translational/clinical innovations in the cancer-research and oncology field.”   

Dr. Eleonora Candi is currently full-professor in Molecular Biology at the University of Rome “Tor Vergata”, Department of Experimental Medicine. Her training started at the Department of Experimental Medicine and Biochemical Sciences of the University of Rome “Tor Vergata”, where in 1995 she received her Ph.D. degree in “Biochemistry and Physiopathology of the Epithelia”, elucidating the mechanisms of cell death during the cornified cell envelope assembly in skin physiological and pathological conditions. Her research activity continued at the Skin Biology Branch, NIAMS, National Institute of Health, Bethesda, MD, USA as post-doctorate fellow until 1998. From 1999 to 2001 she received a Telethon Research Fellowship to study the role of transglutaminases in the genetic disease lamellar ichthyosis. Her research activity then continued at the Department of Experimental Medicine, University of Rome “Tor Vergata”, where in 2003 she was appointed Assistant Professor in Biochemistry and in 2012 as Associate Professor in Molecular Biology. Her major contributions include studies on the role of the transcription factor p63, member of the p53 family, in epithelia development and cancer formation using both in vitro and in vivo models. She investigated the role of microRNAs and long-noncoding RNAs in controlling epithelial progenitor cell fate and recently, the interplay between p63 and epigenetic alterations in squamous cell carcinoma. She has also a solid experience in studying in vivo (murine transgenic animal) epithelial development, homeostasis and carcinogenesis. She is a member of the board of the European Cell Death Organisation (ECDO) and a number of national/international advisory boards. Professor Candi has served as editorial board member on Cell Death & Disease since 2010; The Febs Journal since 2016 and Cell Cycle since 2020.